当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3497381
已选条件
-
T76764Tovetumab;化合物 TovetumabTovetumab
Tovetumab (MEDI-575), an anti-PDGFRα monoclonal antibody, selectively inhibits PDGFRα signal transduction. It is utilized in studying glioblastoma and non-small cell lung cancer (NSCLC) [1] [2].
价 格:¥电议型 号:T76764产 地:中国大陆
-
T76763Teplizumab;替利组单抗PRV-031|||MGA-031;PRV-031|||MGA-031
Teplizumab (MGA-031) is a humanized monoclonal antibody against CD3 that slows the loss of beta cell function.Teplizumab is used to treat type 1 diabetes.
价 格:¥电议型 号:T76763产 地:中国大陆
-
T76762Tabalumab;化合物 TabalumabTabalumab
Tabalumab (LY2127399), a humanized monoclonal antibody (IgG4 type) targeting B-cell activating factor (BAFF), exhibits neutralizing activity against both membrane-bound and soluble BAFF. This compound is relevant for research into autoimmune diseases, including rheumatoid arthritis, renal failure, and systemic lupus erythematosus [1].
价 格:¥电议型 号:T76762产 地:中国大陆
-
T76761Olaratumab奥拉单抗LY3012207|||IMC-3G3
Olaratumab(IMC-3G3) is a human monoclonal IgG1 antibody against platelet-derived growth factor receptor alpha (PDGFRα), which has antitumor effects and can be used to study advanced soft tissue sarcomas.
价 格:¥电议型 号:T76761产 地:中国大陆
-
T76760Sifalimumab;西法木单抗MDX-1103|||MEDI-545;MDX-1103|||MEDI-545
Sifalimumab (MEDI-545) is a monoclonal antibody that targets IFNα and suppresses abnormal immune activity by binding to interferon-alpha.Sifalimumab is used for the treatment of moderate to severe SLE.
价 格:¥电议型 号:T76760产 地:中国大陆
-
T76759Robatumumab;化合物 RobatumumabRobatumumab
Robatumumab (Sch 717454), an anti-human insulin-like growth factor receptor-1 (IGF-1R) antibody, exhibits anti-tumor and anti-proliferative effects on cancer cells. It is applicable in research concerning osteosarcoma and Ewing sarcoma [1] [2].
价 格:¥电议型 号:T76759产 地:中国大陆
-
T76758Rilotumumab;利妥木单抗AMG 102;AMG 102
Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.
价 格:¥电议型 号:T76758产 地:中国大陆
-
T76757Ponezumab;化合物 PonezumabPonezumab
Ponezumab (PF-04360365), a humanized anti-amyloid IgG2 monoclonal antibody, effectively lowers Aβ levels in the central nervous system and enhances learning and memory performance in mouse models. It holds potential for Alzheimer´s disease research [1].
价 格:¥电议型 号:T76757产 地:中国大陆
-
T76756Parsatuzumab;帕萨妥珠单抗RG 7414|||Anti-EGFL7|||MEGF0444A|||MEGF-0444A|||RO-5490248|||M0444A;RG 7414|||Ant
Parsatuzumab (RG 7414) is a humanized monoclonal antibody targeting EGFL7, which is also used as an immunomodulator.Parsatuzumab selectively inhibits the interaction between EGFL7 and endothelial cells, and has an inhibitory effect on endothelial growth factor (VEGF).Parsatuzumab has been used in combination with other compounds for a long time. Combined use to study rectal cancer
价 格:¥电议型 号:T76756产 地:中国大陆
-
T76755Panobacumab;化合物 PanobacumabPanobacumab
Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody developed through the immortalization of human B lymphocytes targeted against the LPS O polysaccharide of P. aeruginosa serotype O11 [1].
价 格:¥电议型 号:T76755产 地:中国大陆
-
T76754Otelixizumab;化合物 OtelixizumabOtelixizumab
Otelixizumab (ChAglyCD3), an anti-human CD3 monoclonal antibody, has potential applications in the study of type 1 diabetes [1].
价 格:¥电议型 号:T76754产 地:中国大陆
-
T76753Olokizumab;化合物 OlokizumabOlokizumab
Olokizumab (CDP 6038) is a humanized monoclonal antibody that targets interleukin-6 (IL-6), primarily utilized in the study of rheumatoid arthritis (RA) [1].
价 格:¥电议型 号:T76753产 地:中国大陆
-
T76752Motavizumab;化合物 MotavizumabMotavizumab
Motavizumab (MEDI-524) is a monoclonal antibody targeting the respiratory syncytial virus (RSV). It is utilized in research focused on RSV infections in high-risk infants [1].
价 格:¥电议型 号:T76752产 地:中国大陆
-
T76751Lenzilumab;化合物 LenzilumabLenzilumab
Lenzilumab (KB 003) is a humanized monoclonal antibody designed to target CSF2/GM-CSF, with applications in COVID-19 and studies on chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) [1] [2].
价 格:¥电议型 号:T76751产 地:中国大陆
-
T76750Cemiplimab;西米普利单抗REGN-2810|||SAR-439684;REGN-2810|||SAR-439684
Cemiplimab (Anti-Human PD-1) is a human monoclonal antibody against programmed cell death receptor 1 (PD-1) and a checkpoint inhibitor that blocks PD-1/PD-L1 mediated T-cell inhibition and can be used in metastatic cancer and squamous cell skin cancer research.
价 格:¥电议型 号:T76750产 地:中国大陆
-
T76749Zilovertamab;泽罗妥单抗Cirmtuzumab|||UC-961;Cirmtuzumab|||UC-961
Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer.
价 格:¥电议型 号:T76749产 地:中国大陆
-
T76748Foralumab;化合物 ForalumabForalumab
Foralumab (NI-0401) is a powerful, orally administered humanized monoclonal antibody that specifically targets the CD3 receptor. By modulating immune responses in NSG mice reconstituted with human hematopoietic stem cells [1], Foralumab exhibits its immunomodulatory effects.
价 格:¥电议型 号:T76748产 地:中国大陆
-
T76747Fletikumab;夫来库单抗Anti-IL-20|||NN-8226|||NNC 0109-0012;Anti-IL-20|||NN-8226|||NNC 0109-0012
Fletikumab (NNC0109-0012) is a monoclonal antibody against IL-20 that is often used as an IL-20 inhibitor.Fletikumab is used in the study of rheumatoid arthritis and psoriasis.
价 格:¥电议型 号:T76747产 地:中国大陆
-
T76746Figitumumab;化合物 FigitumumabFigitumumab
Figitumumab (CP-751871) is a fully human monoclonal antibody targeting the insulin-like growth factor 1 receptor (IGF1R) with high potency. By inhibiting the binding of IGF1 to IGF1R, figitumumab achieves an IC50 value of 1.8 nM, effectively blocking the receptor´s activation [1].
价 格:¥电议型 号:T76746产 地:中国大陆
-
T76745Ficlatuzumab;化合物 FiclatuzumabFiclatuzumab
Ficlatuzumab, a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF), impedes the HGF/c-Met signaling pathway. By blocking this pathway, it prevents c-Met receptor-mediated cancer cell proliferation, migration, and invasion [1].
价 格:¥电议型 号:T76745产 地:中国大陆